ATE211480T1 - Bismaleinsäureimid-vernetzer - Google Patents

Bismaleinsäureimid-vernetzer

Info

Publication number
ATE211480T1
ATE211480T1 AT97903949T AT97903949T ATE211480T1 AT E211480 T1 ATE211480 T1 AT E211480T1 AT 97903949 T AT97903949 T AT 97903949T AT 97903949 T AT97903949 T AT 97903949T AT E211480 T1 ATE211480 T1 AT E211480T1
Authority
AT
Austria
Prior art keywords
enzyme
cyclic
crosslinker
acid imide
linearized
Prior art date
Application number
AT97903949T
Other languages
English (en)
Inventor
Michael J Powell
Lutz F Tietze
Original Assignee
Roche Diagnostics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Corp filed Critical Roche Diagnostics Corp
Application granted granted Critical
Publication of ATE211480T1 publication Critical patent/ATE211480T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT97903949T 1996-01-26 1997-01-23 Bismaleinsäureimid-vernetzer ATE211480T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59201596A 1996-01-26 1996-01-26
PCT/US1997/001130 WO1997027203A1 (en) 1996-01-26 1997-01-23 Bis-maleimido cross-linking agents

Publications (1)

Publication Number Publication Date
ATE211480T1 true ATE211480T1 (de) 2002-01-15

Family

ID=24368925

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97903949T ATE211480T1 (de) 1996-01-26 1997-01-23 Bismaleinsäureimid-vernetzer

Country Status (8)

Country Link
US (1) US5976783A (de)
EP (1) EP0817789B1 (de)
JP (1) JP2863638B2 (de)
AT (1) ATE211480T1 (de)
AU (1) AU1837897A (de)
DE (1) DE69709448T2 (de)
ES (1) ES2170937T3 (de)
WO (1) WO1997027203A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999006072A1 (en) * 1997-07-30 1999-02-11 Boehringer Mannheim Corporation Cyclized prodrugs
GB0125658D0 (en) * 2001-10-25 2001-12-19 Ssl Int Plc Medicaments
US7993749B2 (en) * 2005-12-16 2011-08-09 University Of Kansas Nanoparticles comprising a nanoparticle template and a polymer shell having an amide side chain, and method of making thereof
US20130041134A1 (en) * 2009-11-05 2013-02-14 Sangart ,Inc. Methods for preparing polyethylene glycol maleimide using n-(2-hydroxyethyl) maleimide as a starting material
JP6590474B2 (ja) * 2014-09-25 2019-10-16 国立大学法人埼玉大学 化学架橋ペプチドの作製方法、その方法を用いて作製した化学架橋ペプチド及びそのペプチドを用いて構築したｃＤＮＡディスプレイ法によるペプチドライブラリ

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4671958A (en) * 1982-03-09 1987-06-09 Cytogen Corporation Antibody conjugates for the delivery of compounds to target sites
US4493795A (en) * 1983-10-17 1985-01-15 Syntex (U.S.A.) Inc. Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
US4708929A (en) * 1984-10-29 1987-11-24 Microgenics Corporation Methods for protein binding enzyme complementation assays
EP0199801B1 (de) * 1984-10-29 1993-08-25 MICROGENICS CORPORATION (a Delaware corporation) Ergänzungstestverfahren von proteine bindenden enzymen
US4766106A (en) * 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
CA1340387C (en) * 1987-10-30 1999-02-09 Carol A. Schlesinger Heterobifunctional coupling agents
DE3885431D1 (de) * 1987-12-23 1993-12-09 Boehringer Ingelheim Int Expression der viral kodierten Protease P2A des HRV2.
JPH04504713A (ja) * 1988-11-18 1992-08-20 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 共役ポリペプチドとその調製および使用方法
US5166322A (en) * 1989-04-21 1992-11-24 Genetics Institute Cysteine added variants of interleukin-3 and chemical modifications thereof
CA1335707C (en) * 1989-08-15 1995-05-30 Pyare Khanna Drug screening assay
EP0419081A3 (en) * 1989-09-22 1992-07-22 Microgenics Corporation Method for protein binding enzyme complementation assays
US5164300A (en) * 1989-12-28 1992-11-17 Washington University Method for determining activity of retroviral protease
US5011910A (en) * 1989-12-28 1991-04-30 Washington University Reagent and method for determining activity of retroviral protease
JPH05506999A (ja) * 1990-08-28 1993-10-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ウイルスプロティナーゼの活性をモニターするためのテスト系
US5171662A (en) * 1990-09-13 1992-12-15 The Upjohn Company Method of detecting HIV protease activity
CA2068190C (en) * 1991-05-15 1996-12-17 Microgenics Corporation Methods and compositions for enzyme complementation assays using the omega region of beta-galactosidase
CA2075858C (en) * 1991-08-15 1998-05-19 Scott J. Eisenbeis Detection of complementary nucleotide sequences
US5412083A (en) * 1992-04-16 1995-05-02 Northeastern University Carbohydrate heterobifunctional cross-linking reagent
DE4310141A1 (de) * 1993-03-29 1994-10-06 Boehringer Mannheim Gmbh Homobidentale trifunktionelle Linker
US5436131A (en) * 1993-04-02 1995-07-25 Merck & Co., Inc. Color screening assay for identifying inhibitor resistant HIV protease mutants
US5439798A (en) * 1993-12-17 1995-08-08 Boehringer Mannheim Corporation Maleimide adduct conjugates of procainamide and NAPA
US5506115A (en) * 1994-04-29 1996-04-09 G. D. Searle & Co. Reagent and method for determining activity of herpes protease
WO1996012492A1 (en) * 1994-10-25 1996-05-02 Merck & Co., Inc. Microbial synthesis of hiv protease inhibitors
US5861267A (en) * 1995-05-01 1999-01-19 Vertex Pharmaceuticals Incorporated Methods, nucleotide sequences and host cells for assaying exogenous and endogenous protease activity
AU6754196A (en) * 1995-08-25 1997-03-19 Rational Drug Design Laboratories Novel fluorescent substrate for assaying activity of hepatitis c virus ns3 serine protease

Also Published As

Publication number Publication date
DE69709448T2 (de) 2002-09-19
DE69709448D1 (de) 2002-02-07
EP0817789B1 (de) 2002-01-02
EP0817789A1 (de) 1998-01-14
WO1997027203A1 (en) 1997-07-31
AU1837897A (en) 1997-08-20
US5976783A (en) 1999-11-02
JPH10508040A (ja) 1998-08-04
JP2863638B2 (ja) 1999-03-03
ES2170937T3 (es) 2002-08-16

Similar Documents

Publication Publication Date Title
Bittner et al. Isolated light chains of botulinum neurotoxins inhibit exocytosis: studies in digitonin-permeabilized chromaffin cells
Dingle Studies on the mode of action of excess of vitamin A. 3. Release of a bound protease by the action of vitamin A
Okamoto et al. CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration
DE122006000007I2 (de) -tragenden b-lymphocyten befinden.
ATE462012T1 (de) Ezymatisches verfahren zur herstellung von 2-o- glyceryl-alpha-d-glucopyranosid
ATE356869T1 (de) Bildung von xenogenen antikörpern
DK1017692T3 (da) 4-Heteroaryl-tetrahydroquinoliner og deres anvendelse som inhibitorer af cholesterolester-transferproteiner
ATE309378T1 (de) Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung
KR850005454A (ko) 환상 폴리펩타이드의 제조방법
ATE474926T1 (de) Verwendung von clya hemolysin fur ausscheidung von fusionprotein
DK0819135T3 (da) Kulhydratmodificerede cytostatika
ES2157978T3 (es) Edulcorante de brazeina.
Kelly et al. β-Bungarotoxin, a phospholipase that stimulates transmitter release
CA2241782A1 (en) Cross-linked polypeptide fragments of .beta.-galactosidase
Hussain et al. The calcium sensor synaptotagmin 1 is expressed and regulated in hippocampal postsynaptic spines
TR200102031T2 (tr) Hücre yapışma önleyicileri olarak monosakkaritlerin türevleri
DE69709448D1 (de) Bismaleinsäureimid-vernetzer
WO2001042784A3 (en) Methods for screening compounds active on neurons
WO2001040519A8 (en) Methods for identifying modulators for balance related disorders
AU6997794A (en) Process for screening substances having a modulating effect on an interleukine-5-receptor-dependent cellular signal transmission path
ATE44621T1 (de) Proteinkonjugate von penicillosaeure, ihre herstellung und verwendung.
Ito et al. The effect of calcium-ionophores on acetylcholine release from Schwann cells
Šmigáň et al. The presence of H+ and Na+‐translocating ATPases in Methanobacterium thermoautotrophicum and their possible function under alkaline conditions
FI920663A0 (fi) Polyhydroxicyklopentanderivat, deras framstaellning och terapeutiska anvaendning.
DE69829953D1 (de) Kristallisation von proteinen